News

Prefilled Syringes Market Size to Reach US$ 15.00 Billion by 2030, Driven by Increasing Prevalence of Chronic Diseases - The Insight Partners
The global prefilled syringes market share is projected to grow from US$ 6.69 Billion in 2022 to US$ 15.0 Billion by 2030, ...
Pharmacies often won't sell syringes without a prescription, exacerbating bloodborne disease transmission
More than two-fifths of Oregon community pharmacies require a prescription to purchase syringes, even though they can be sold ...
Mena FN13d
Prefilled Syringes Market Size To Reach US$ 15.00 Billion By 2030, Driven By Increasing Prevalence Of Chronic Diseases - The Insight Partners
(MENAFN- GlobeNewsWire - Nasdaq) The global prefilled syringes market share is projected ... Insight Partners,“ Prefilled Syringe Market Size and Forecasts (2022 - 2030), Global and Regional ...
EurekAlert!7d
Pharmacies often won’t sell syringes without a prescription, exacerbating bloodborne disease transmission
The researchers chose the 10-pack of syringes because it’s commonly sold at such pharmacies and more closely aligned with the needs of a person who injects drugs than the other regular size ...
News-Medical.Net7d
A smarter alternative to syringe pumps for precision fluid dispensing
The FENYX is valveless and able to self-prime 10x-40x faster than a syringe pump, helping OEMs eliminate unnecessary fluidic ...
New Birth Control Shot Transforms Into a Long-Lasting Implant—No Clinic Required
The new approach delivers the contraceptive hormonal medication levonorgestrel via what the researchers call “Self-assembling ...
Retractable Technologies (NYSE:RVP) Coverage Initiated at StockNews.com
Research analysts at StockNews.com began coverage on shares of Retractable Technologies (NYSE:RVP – Get Free Report) in a research report issued to clients and investors on Friday. The firm set a ...